0001493152-24-050785.txt : 20241219 0001493152-24-050785.hdr.sgml : 20241219 20241219162730 ACCESSION NUMBER: 0001493152-24-050785 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241219 DATE AS OF CHANGE: 20241219 EFFECTIVENESS DATE: 20241219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scienture Holdings, Inc. CENTRAL INDEX KEY: 0001382574 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-532779 FILM NUMBER: 241563693 BUSINESS ADDRESS: STREET 1: 2420 BRUNELLO TRACE CITY: LUTZ STATE: FL ZIP: 33558 BUSINESS PHONE: (800) 261 0281 MAIL ADDRESS: STREET 1: 2420 BRUNELLO TRACE CITY: LUTZ STATE: FL ZIP: 33558 FORMER COMPANY: FORMER CONFORMED NAME: TRxADE HEALTH, INC DATE OF NAME CHANGE: 20210602 FORMER COMPANY: FORMER CONFORMED NAME: TRXADE GROUP, INC. DATE OF NAME CHANGE: 20140207 FORMER COMPANY: FORMER CONFORMED NAME: XCELLINK INTERNATIONAL INC. DATE OF NAME CHANGE: 20081230 D 1 primary_doc.xml X0708 D LIVE 0001382574 Scienture Holdings, Inc. 6308 BENJAMIN ROAD, SUITE 708 TAMPA FL FLORIDA 33634 (408) 459-7579 DELAWARE TRxADE HEALTH, INC. Trxade Group Inc. TRxADE HEALTH, INC TRXADE GROUP, INC. XCELLINK INTERNATIONAL INC. Corporation true Surendra Ajjarapu 6308 Benjamin Road, Suite 708 Tampa FL FLORIDA 33634 Executive Officer Director Prashant Patel 6308 Benjamin Road, Suite 708 Tampa FL FLORIDA 33634 Executive Officer Director Mayur Doshi 6308 Benjamin Road, Suite 708 Tampa FL FLORIDA 33634 Director Donald Fell 6308 Benjamin Road, Suite 708 Tampa FL FLORIDA 33634 Director Shankar Hariharan 20 Austin Blvd. Commack NY NEW YORK 11725 Director Subbarao Jayanthi 6308 Benjamin Road, Suite 708 Tampa FL FLORIDA 33634 Director Narasimhan Mani 20 Austin Blvd. Commack NY NEW YORK 11725 Director Pharmaceuticals Decline to Disclose 06b false 2024-11-25 false true true true false 0 3333333 3333333 0 false 2 210000 0 0 Proceeds are to be used for general working capital purposes, which may include payment of ordinary course renumeration to officers. false Scienture Holdings, Inc. /s/ Surendra Ajjarapu Surendra Ajjarapu Chief Executive Officer 2024-12-19